Meseclazone
Meseclazone (W-2395), also known as 2-methylseclazone, is a nonsteroidal anti-inflammatory drug (NSAID) developed in the 1970s.[1][2] It functions as a prodrug to the 5-chloro derivative of salicyclic acid.[2] It was never marketed on account of toxicity issues, namely pertaining to the liver.[2]
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C11H10ClNO3 |
| Molar mass | 239.66 g·mol−1 |
| 3D model (JSmol) | |
| |
See also
- Salicyclic acid
References
- Dictionary of organic compounds. London: Chapman & Hall. 1996. ISBN 0-412-54090-8.
- Rainsford, K. D. (2004). Aspirin and related drugs. Washington, DC: Taylor & Francis. ISBN 0-7484-0885-1.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.